Living the Long Life

What are some of the consequences of an aging population?

Lilly’s Boom Meets Resistance

Eli Lilly’s earnings soared, but Lilly faces regulatory risks and competitive pressure.

Weighing In

How dominant is Novo Nordisk and Eli Lilly’s position in the pharmaceutical industry?

Novo – Lilly: Building Capacity

Find out how Eli Lilly and Novo Nordisk have been dealing with the demand for their obesity drugs.